FOXR2 and medulloblastoma: Subtyping based on methylation profiling for the PB-MYC/FOXR2 tumors appeared difficult for several cases as in 6 tumors no clearly matching score in the Heidelberg classifier v12.5 were found and in 5 of these cases the highest available score was even for subtype III medulloblastoma (not shown).